Skip to content

Checked

Donor-Derived Ex-Vivo Expanded Natural Killer Cell Infusions in Children and Young Adults With High Risk Acute Myeloid Leukemia Receiving Myeloablative HLA-Haploidentical Hematopoietic Cell Transplant

NCT04836390 on ClinicalTrials.gov

Study listings come from ClinicalTrials.gov, where sponsors register and update their own studies. A listing does not mean a study is safe or effective, and DatenUS does not recommend any study. Talk with your doctor before joining a clinical trial, and use ClinicalTrials.gov for contact details and full eligibility rules.

Status
Enrolling by invitation
Phase
Phase 2
Interventional
Planned enrollment
30
Participants, all sites
U.S. sites
13
In 11 states

Study details

Conditions
Acute Myeloid Leukemia
Sponsor
Michael Pulsipher (University, hospital or other organization)
Ages
0 to 25 years
Sex
All
Healthy volunteers
Not accepted
Start
08/24/2021
Primary completion (expected)
May 2026
Last updated by sponsor
05/04/2025

Full eligibility rules, contacts and site names: NCT04836390 on ClinicalTrials.gov

Where the study has sites

Cities with at least one listed U.S. site. Some sites may not be enrolling yet.

  • Arizona: Phoenix
  • California: Los Angeles
  • Colorado: Aurora
  • Florida: Orlando, St. Petersburg
  • Illinois: Chicago
  • Missouri: St Louis
  • New York: Valhalla
  • Ohio: Cleveland, Columbus
  • Utah: Salt Lake City
  • Washington: Seattle
  • Wisconsin: Milwaukee

More studies on the same topic

Frequently asked questions

What does recruiting mean?
Recruiting means the study is currently enrolling participants. Not yet recruiting means it has been registered but has not started enrolling. Enrolling by invitation means participants are selected by the study team rather than through open enrollment.
How do I join a clinical trial?
Read the full eligibility criteria and contact information on ClinicalTrials.gov, then talk with your doctor about whether a study may be right for you. The study team decides who can enroll.

Source: ClinicalTrials.gov, National Library of Medicine · Last updated 05/04/2025